| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.018 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |